References
- Stephenson J. Cancer studies explore targeted therapy, researchers seek new prevention strategies. JAMA 2002; 287: 3063–3067
- De Bono J.S., Rowinsky E.K. The ErbB receptor family: a therapeutic target for cancer. Trends Mol. Med. 2002; 8: S19–S26
- Crone S.A., Zhao Y.Y., Fan L., Gu Y., Minamisawa S., Liu Y., Peterson K.L., Chen J., Kahn R., Condorelli G., Ross J., Jr, Chien K.R., Lee K.F. ErbB2 is essential in the prevention of dilated cardiomyopathy. Nature Med. 2002; 8: 459–465
- Inui A. Transgenic approach to the study of body weight regulation. Pharmacol. Rev. 2000; 52: 35–61